APA (7th ed.) Citation

M, O., Y, J., C, H. C., ZI, O., G, G., N, S., . . . U, S. (2025). Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations. JAMA network open, 8(10), e2534968. https://doi.org/10.1001/jamanetworkopen.2025.34968

Chicago Style (17th ed.) Citation

M, Ostrowski, et al. "Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations." JAMA Network Open 8, no. 10 (2025): e2534968. https://doi.org/10.1001/jamanetworkopen.2025.34968.

MLA (9th ed.) Citation

M, Ostrowski, et al. "Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations." JAMA Network Open, vol. 8, no. 10, 2025, p. e2534968, https://doi.org/10.1001/jamanetworkopen.2025.34968.